Validation has already been provided within the scientific community via MSK collaboration. AZN just provided the warning shot with Phase I collab and sent off a second with Phase 2 trial.
I'm grabbing all the shares below $2. Positive Sunrise results and I have an easy 10 bagger please for starters from the current PPS. Besides Full Enrollment PR coming $$$$$
Market Data 
Markets 
AI
